SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRentokil Initial Regulatory News (RTO)

Share Price Information for Rentokil Initial (RTO)

Share Price is delayed by 15 minutes
Get Live Data
453.60    3.80 (0.84%)
Bid:
452.90
Ask:
453.20
Spread: 0.30 (0.066%)
Market Cap: £11.41b
RTO Live PriceLast checked at - London Stock Exchange

Intraday Rentokil Initial Share Chart

?50m Floating Rate Notes due 2013

14 Oct 2008 12:52

RNS Number : 8049F
Rentokil Initial PLC
14 October 2008
Β 

ο»Ώ

Rentokil Initial plc

Β£50m Floating Rate Notes due 2013

Rentokil Initial plcΒ (theΒ "Company")Β announces that it has entered into a commitment with an investorΒ who will purchase Β£50m Floating Rate Notes due 2013Β (the "FRNs"). TheΒ FRNsΒ are expected to beΒ issuedΒ at parΒ underΒ the Company'sΒ existingΒ Euro Medium Term Note ProgrammeΒ and carry a coupon of LIBOR +Β 3.25%.Β Β The FRNs are expected to be issued before the end ofΒ October 2008Β and to beΒ guaranteed by Rentokil Initial 1927 plc, a wholly owned subsidiary of the Company.

Rentokil Initial 1927 plcΒ currently guarantees the obligations ofΒ the CompanyΒ to its bondholders, banks and certain other financial counterparties. These guaranteesΒ wereΒ due to expire on 19Β November 2008Β but will nowΒ be extendedΒ toΒ match the maturity of the Company's Β£300Β millionΒ 5.75 per cent.Β NotesΒ dueΒ 2016,Β issued by the Company inΒ March 2006, and the FRNs, whicheverΒ maturityΒ is the later.

During the last two months, Rentokil Initial has announced the issue of Β£125m of newΒ debt securities (beingΒ the FRNs and theΒ Β£75 million Floating Rate Reset Notes due 2033 (the "PCRs")). TheΒ Company's Β£250m 6.125 per cent. notes due 2008 (the "Notes")Β will mature on 19Β November 2008 and will be repaid from the Company's bank facilities. The Company estimates that it will have at least Β£350m ofΒ headroomΒ in its committed facilities after repaying theΒ Notes.Β Β At least Β£100m ofΒ thatΒ headroomΒ isΒ provided by a facility whichΒ is due toΒ expireΒ in 2012. The balance is provided by a second facility which is extendable at the Company's option toΒ JanuaryΒ 2010.Β 

After November 2008, the next maturityΒ of the Company's bond indebtedness will be in 2013 if the holders of the PCRs exercise their right toΒ require repayment.

For further information

Shareholder/analyst enquiries:

Katharine Rycroft, Head of Investor Relations Rentokil Initial plc 020 7592 2700

Media enquiries:

Malcolm Padley, Head of Corporate Communications Rentokil Initial plc 020 7592 2700

This information is provided by RNS
The company news service from the London Stock Exchange
Β 
END
Β 
Β 
MSCFFUFFLSASELS
Date   Source Headline
21st May 20267:00 amRNSAppointment of CEO, North America
8th May 202610:30 amRNSHolding(s) in Company
7th May 20264:40 pmRNSResult of AGM
23rd Apr 20264:25 pmRNSFinal Dividend – Pence Sterling Amount Payable
23rd Apr 20262:30 pmRNSIssuance of $500 million 4.625% Notes due 2031
21st Apr 202610:30 amRNSHolding(s) in Company
16th Apr 20267:00 amRNSQ1 Trading Update
15th Apr 20267:00 amRNSDirectorate Change
30th Mar 202610:30 amRNSHolding(s) in Company
26th Mar 20263:46 pmRNSDirector/PDMR Shareholding
25th Mar 202610:50 amRNSAnnual Financial Report
17th Mar 20264:30 pmRNSDirector/PDMR Shareholding
16th Mar 202610:32 amRNSHolding(s) in Company
16th Mar 202610:32 amRNSHolding(s) in Company
12th Mar 202610:30 amRNSHolding(s) in Company
10th Mar 20264:28 pmRNSDirector/PDMR Shareholding
10th Mar 20264:28 pmRNSDirector/PDMR Shareholding
10th Mar 20264:26 pmRNSDirector/PDMR Shareholding
10th Mar 20264:26 pmRNSDirector/PDMR Shareholding
9th Mar 202611:15 amRNSHolding(s) in Company
5th Mar 20267:00 amRNSPreliminary Results
5th Mar 20267:00 amRNSChair Succession Planning Update
23rd Feb 202610:30 amRNSHolding(s) in Company
19th Feb 20262:50 pmRNSDirector Declaration
12th Feb 20265:30 pmRNSNotice of Early Redemption
20th Jan 202610:25 amRNSHolding(s) in Company
19th Jan 202610:30 amRNSHolding(s) in Company
16th Jan 20263:00 pmRNSHolding(s) in Company
14th Jan 202610:30 amRNSHolding(s) in Company
13th Jan 202610:30 amRNSHolding(s) in Company
13th Jan 20267:00 amRNSDirectorate change
19th Dec 202511:00 amRNSDirector/PDMR Shareholding
19th Dec 202511:00 amRNSDirector/PDMR Shareholding
5th Dec 202510:30 amRNSHolding(s) in Company
5th Dec 202510:30 amRNSHolding(s) in Company
26th Nov 20254:25 pmRNSHolding(s) in Company
28th Oct 202510:45 amRNSHolding(s) in Company
28th Oct 202510:45 amRNSHolding(s) in Company
27th Oct 202510:30 amRNSHolding(s) in Company
23rd Oct 202511:45 amRNSHolding(s) in Company
23rd Oct 20257:00 amRNSQ3 Trading Update
21st Oct 202510:00 amRNSHolding(s) in Company
14th Oct 202510:00 amRNSHolding(s) in Company
1st Oct 202510:30 amRNSBlock listing Interim Review
30th Sep 202510:30 amRNSCompletion of France Workwear business sale
25th Sep 20254:15 pmRNSDirector/PDMR Shareholding
24th Sep 20256:00 pmRNSDirector Declaration
26th Aug 202512:30 pmRNSInterim Dividend – Pence Sterling Amount Payable
7th Aug 202511:10 amRNSHolding(s) in Company
31st Jul 20257:00 amRNSHalf-year Report

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.